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The aims of the present study were to provide quantitative data on the impact of air pollution on the health of
people living in Tehran city, the most populated city of Iran. The approach proposed by the World Health
Organization (WHO) was applied using the AirQ 2.2.3 software developed by the WHO European Centre for
Environment and Health, Bilthoven Division. Concentrations of ozone, nitrogen dioxide, sulfur dioxide and
particulate matter of aerodynamic diameter ≤ 10 μm (PM10) were used to assess human exposure and health
impacts in terms of attributable proportion of the health outcome, annual number of excess cases of mortality for
all causes, and cardiovascular and respiratory diseases. The annual average of PM10, SO2, NO2 and O3 in Tehran
were 90.58, 89.16, 85 and 68.82 μg/m3, respectively. Considering short-term effects, PM10 had the highest health
impact on the 8,700,000 inhabitants of Tehran city, causing an excess of total mortality of 2194 out of 47284 in a
year. Sulfur dioxide, nitrogen dioxide and ozone caused about, respectively, 1458, 1050 and 819 excess cases of
total mortality. Results indicate that the magnitude of the health impact estimated for the city of Tehran
underscores the need for urgent action to reduce the health burden of air pollution.
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Exposure to air pollution can cause both acute (short-
term) and chronic (long-term) health effects. The acute
effects of air pollution on human health were amply
proven in the 20th century, when severe air pollution in
Europe (Meuse Valley and London) and in the United
States (Donora, Pa) caused deaths and disease in hun-
dreds of thousands of people [1,2]. This episode has
demonstrated that high concentrations of air pollution
lead to an increase in mortality [2] and morbidity. In
later studies, investigators found that levels below even
current air pollution guidelines are associated with ad-
verse effects on health [3-13] and air quality standards
may not be protective enough for the most sensitive
groups [14]. In addition, even though pollution due to
combustion fuels has fallen dramatically in recent years,
emerging pollutants such as O3 and NOX, and changes* Correspondence: hassanvand@razi.tums.ac.ir
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reproduction in any medium, provided the orin the composition and size distribution of particulate
matter, have become important in the health effects of
air pollution [3,15].
The present study assessed the health impact of air
quality on the residents of Tehran, the capital city of
Iran, the largest urban area of Iran with a population of
8,700,000 in 2011 (Figure 1) [16]. The city also is ranked
as one of the largest cities in Western Asia and 19th in
the whole world. As in other large cities, Tehran is faced
with serious air quality problems. In general, 20% of the
total energy of the country is consumed in Tehran. Pol-
lutants such as PM10, SO2, NO2, HC, O3 and CO are the
major air pollutants in Tehran, about 80-85% of which is
produced by mobile sources of pollution [8].
The city has a capacity for 700,000 registered cars yet
3 million roam its streets on a daily basis. Compounding
Tehran’s air pollution problem is its geographical loca-
tion. With the location of 35° 41' N - 51° 25' E and alti-
tude of 1000–1800 meters above mean sea level, Tehran
is located in valleys and is surrounded on the north,
northwest, east and southeast by high to medium high
(3800–1000 m) mountain ranges. The mountain rangel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Map of the study area and locations of monitoring stations (Monitoring S) with valid observations.
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prevents the polluted air from being carried away from
the city. Thus, during winter, the lack of wind and cold
air causes the polluted air to be trapped within the city.
These concomitant conditions make Tehran as one of
the worst areas in the world for atmospheric pollution
with many days exceeding air quality standards during
each year [17]. Because of the air pollution in the Great
Tehran area, morbidity, mortality and symptoms
emerge. At the moment, the concentration of these pol-
lutants is higher than the standard level most of the time
which means that they have numerous effects on the
health of Tehran citizens [8].
Up to now the human health endpoints of air pollu-
tion has not been quantified in Tehran. The main aim of
this study was the quantification of the short-term
health effect of air pollutants for people living in Tehran,
by using World Health Organization (WHO) approach.
Materials and methods
AirQ software
The approach proposed by the WHO was adopted using
the Air Quality Health Impact Assessment (AirQ 2.2.3)
software developed by WHO European Centre for Envir-
onment Health, Bilthoven Division. This program is
used to estimate the impact of exposure to specific at-
mospheric pollutants on the health of people living in a
certain period and area. The assessment is based on the
attributable proportion (AP), defined as the fraction of
the health outcome in a certain population attributable
to exposure to a given atmospheric pollutant, assuminga proven causal relation between exposure and health
outcome and no major confounding effects in that asso-
ciation. The AP can be easily calculated by the following
general formula [18]:
AP ¼ Σ RR cð Þ  1½   P cð Þf g
Σ RR cð Þ  P cð Þ½  ð1Þ
Where AP is the attributable proportion of the health
outcome, RR is the relative risk (RR) for a given health
outcome, in category “c” of exposure, obtained from the
exposure–response functions derived from epidemio-
logical studies and P(c) is the proportion of the popula-
tion in category “c” of exposure.
If the baseline frequency of the health outcome in the
population under investigation is known, the rate attrib-
utable to the exposure can be calculated as
IE ¼ I  AP ð2Þ
Where IE is the rate of the health outcome attributable
to the exposure and I is the baseline frequency of the
health outcome in the population under investigation.
Finally, knowing the size of the population, the num-
ber of cases attributable to the exposure can be esti-
mated as follows:
NE ¼ IE N ð3Þ
Where NE is the number of cases attributed to the ex-
posure and N is the size of the population investigated.
RR gives the increase in the probability of the adverse
effect associated with a given change in the exposure
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day changes in air pollutants over long periods were
related to daily mortality, hospital admissions and other
public health indicators. RR values used in the present
assessment are shown in Table 1. The RR values used
for PM10 were summary estimates derived from a quan-
titative meta-analysis of peer-reviewed studies focused
on European investigations [19], while for SO2 the RR
implemented in the software and proposed as summary
estimate in the WHO Air Quality Guidelines for Eur-
ope [20] was used. Finally, for O3 and NO2 the RR
values came directly from published studies on short-
term effects within the Air Pollution and Health: a
European Approach (APHEA) project [21,22]. The
baseline rates of all mortality for the calendar year 2010
were obtained from death certificates recorded at the
Civil Registration Office of Tehran. For hospital admis-
sions, the baseline rates that proposed by WHO were
used.
Exposure assessment
Air concentrations of the selected pollutants in the
area of interest were measured by Tehran Air Quality
Control Corporation (TAQCC), Iran, using 25 perman-
ent monitoring stations (Figure 1). Finally, the airTable 1 Relative risk (RR) with 95% confidence intervals (95%
2.2.3 software and used for the health effect estimates































a Crude rate per 100,000 inhabitants.
b International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-cm
c 1 h average.
d Daily average.
e 8 h “moving average”.
f Hospital admissions.
g Chronic obstructive pulmonary disease.pollutants data from the permanent monitoring station
of Tehran city from January 2010 to January 2011 year
were used.
There are 25 stations for the measurement of air pol-
lution in Tehran, but some of them, based on WHO
Criteria for Air Quality Health Impact Assessment, had
an invalid data for assessment. Finally, data from 7, 10,
11, 13 and 13 stations located in north, west, south and
central parts of Tehran that were consistently active dur-
ing the study period for, respectively, PM10, SO2, NO2
and O3, were used.
For all the pollutants, the parameters required by the
software (annual and seasonal maximum and annual
98th percentiles) were obtained and concentrations were
recorded to 10 μg/m3 categories, corresponding to
equivalent exposure categories. For O3, data were
expressed as an 8 h “moving average”; for NO2, as a 1 h
average concentrations and for SO2 and PM10 as daily
averages.
Exposure was estimated considering the city of Tehran
as single agglomerate, with a residential population
8,700,000 people. The software assumes that concentra-
tions measured are representative of the average expos-
ure of the people. For example, if on 5% of sampling
days concentrations were between 10 and 20 μg/m3, itCI), and corresponding reference, implemented in AirQ















































Table 2 Summary of the concentrations of air pollutants, and meteorological variables, Tehran (2010–2011)
Mean (SD) Minimum P25 P50 P75 P98 Maximum No. of station No. of days
PM10, Annual 24 h (μg/m
3) 90.58 (41.99) 22.54 60.34 86.65 114.80 175.68 329.95 7 2438
SO2, Annual 24 h (μg/m
3) 89.16 (29.27) 45.47 69.24 84.47 101.60 161.45 313.27 10 3172
NO2, Annual 24 h (μg/m3) 85 (24.183) 49.37 68.88 77.72 95.70 145.88 163.85 13 4115
O3, Annual 8 h (μg/m3) 68.82 (40.48) 10.88 35.32 59.75 99.28 158.60 187.16 11 3530
Temperature (°C) 19.68 (9.87) −5 10.69 21.10 28.92 38.12 42 365
Relative humidity (%) 38.87 (16.45) 6 27.82 34.23 48.70 62.84 100 365
No. Station: number of monitoring stations with valid observations.
No. days: number of days with valid observations.
Naddafi et al. Iranian Journal of Environmental Health Sciences & Engineering 2012, 9:28 Page 4 of 7
http://www.ijehse.com/content/9/1/28was assumed that people were exposed to the corre-
sponding concentration for 5% of their time.
Results
Table 2 shows the summary of the statistics of environ-
mental data in Tehran.
The highest PM10 concentration was detected in the
summer period with maximum value of 329.95 μg/m3.
For O3 the maximum 8 h average concentration was
187 μg/m3 detected as expected in summer, while the
maximum NO2 and SO2 concentrations, respectively,
163.85 and 313.27 μg/m3 were detected in winter.
The obtained results show that annual average of































Concentration for O 3 (µg/m 3)
C
Figure 2 Percentage of days on which people in Tehran are exposed
and (D) O3.(71 μg/m3) [17] and 4.5 times the guideline values pre-
scribed by the WHO [28]. Also the annual average of
NO2 in Tehran was 2.1 times the guideline value pre-
scribed by the WHO [28].
Figure 2A–D illustrates the concentrations of different
pollutants and the percentage of time to which people
were exposed to these concentrations. The data were
used to estimate the short- term effects.
The short-term health impacts of exposure to PM10,
SO2, NO2 and O3 above a reference value of 10 μg/m
3
are shown in Table 3. The figures represent the esti-
mated AP and number of excess cases in comparison to
the cases if concentration values of the pollutants were


































Concentration for NO 2 (Daily Ave) (µg/m 3)
D
to different concentrations of (A) PM10, (B) SO2, (C) NO2
Table 3 Estimated attributable proportion (AP) expressed as percentage and number of excess cases in a year due to
short-term exposure above 10 μg/m3 for PM10, SO2, O3 and NO2
Health Endpoints Air pollutants AP (uncertainty range)a No. of excess cases (uncertainty range)a
Total mortality PM10 4.6 (3.14-6) 2194 (1486–2880)
SO2 3 (2.33-3.67) 1458 (1102–1739)
NO2 2.2 (1–2.93) 1050 (705–1389)
O3 1.73 (1.16-2.85) 819 (549–1349)
Cardiovascular mortality PM10 6.8 (3.89-9.35) 1367 (738–1916)
SO2 5.98 (1.56-8.7) 1202 (315–1751)
NO2 2.93 (2.22-3.64) 591 (446–733)
O3 2.85 (1.16-3.95) 574 (233–794)
Respiratory mortality PM10 9.53 (3.89-13.95) 402 (164–588)
SO2 7.73 (4.55-10) 310 (192–422)
O3 7 (3.4-8) 299 (143–341)
Hospital Admissions Cardiovascular Disease PM10 6.8 (4.64-9.53) 2580 (1760–3617)
Hospital Admissions Respiratory Disease PM10 6.09 (3.74-8.32) 6677 (4107–9126)
Hospital Admissions COPD NO2 2.79 (0.3-6.64) 247 (27–586)
O3 4.80 (2.52-7.09) 424 (222–626)
SO2 3.38 (0–8.04) 298 (0–710)
Acute Myocardial Infarction SO2 4.84 (2.02-7.43) 556 (233–854)
NO2 2.65 (1.12-5.97) 305 (129–687)
a Obtained using the lower and upper RR values.
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(Table 3) were based on the RR values from the
APHEA-2 project, which investigated health effects of
ambient O3 in 23 European cities/areas for at least three
years [21]. For NO2 the estimated short-term effects
(Table 3) are based on the pooled estimates for the in-
crease in mortality associated with an increase of 10 μg/
m3 in 30 European cities participating in the APHEA-2
project [22].Discussion
This paper offers a study case using the WHO approach
to assess the impact of atmospheric pollution on human
health for people living in Tehran, one of the most
populated areas in the world, where the geographical
features make the air quality among the worst in the
world. The impact was estimated as the increase in all-
causes, cardiovascular and respiratory mortality, and
hospital admissions for cardiovascular and respiratory
diseases, COPD and acute myocardial Infarction for
short-term exposure.
Considering short-term effects, PM10 had the greatest
health impact on the 8,700,000 inhabitants of Tehran
city, causing an excess of total mortality of 2,194 out of
47,284 people in a year. The effect of SO2, NO2 and O3
on total mortality was an excess of about, respectively,
1458, 1050 and 819 cases in a year.The AirQ software has been used by other investiga-
tors to assess the human health impact of PM2.5 [15,29]
or PM10 [30]. [15] estimated the human health risk in
relation to air quality in two municipalities in an indus-
trialized area of Northern Italy, the authors found that
PM2.5 had the highest health impact on the 24,000 inha-
bitants of the two small towns, causing an excess of total
mortality of 8 out of 177 in a year; also Ozone and nitro-
gen dioxide each caused about three excess cases of total
mortality. [30] focused on short-term effects of PM10 in
Trieste (about 200,000 inhabitants), a city in north-east
Italy; For PM10 concentrations above 20 μg/m
3, 52, 28
and 6 cases in excess, respectively, were estimated for
total, cardiovascular and respiratory mortality. These fig-
ures, if normalized to the population in Tehran
(8,700,000 inhabitants), would result in a number of ex-
cess cases very similar to those reported for PM10 in
Table 2.
In another study, [31] found in Milan (1,308,000 inha-
bitants), a big industrial city in the Po Valley, the central
estimate of the number of excess cases attributable to
PM10 was 677 for total mortality. In a study of PM10 and
O3 impact on human health in 13 Italian cities, with
about nine million inhabitants during the period 2002–
2004, [32] it was reported that on average 8220 deaths a
year, excluding accidental causes, were attributable to
PM10 above 20 μg/m
3. For O3 the effect was estimated
at 516 extra deaths yearly. For short-term effects
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3 was responsible for
1372 extra deaths.
Results obtained from studies of health effects of air
pollution in various parts of the world differ. Particulate
matter is the pollutant with the biggest health effects in
all of these papers, including the present study.
This study has several limitations. One of the limita-
tions of this approach is that the health impact focuses
on individual compounds without considering the simul-
taneous exposure to several, which is what actually
occurs [15]. The health effects of atmospheric pollution
are indeed the consequence of interactions between dif-
ferent air contaminants, and between these and other
compounds of natural origin. Generally, in quantitative
assessments of health effects, the interactions between
different contaminants are not investigated as it would
require a good knowledge of the mechanisms of toxicity
for the different compounds, which is rarely available. In
order to take account of co-exposure to different pollu-
tants, it is often assumed that the health effects of indi-
vidual compounds are additive. However the simple
addition of the effects of the single pollutants would
not be right because atmospheric pollutants are usually
positively related.
A further limitation related to the exposure assessment
is that the approach assumes that concentrations mea-
sured in specific sampling points are representative of
the average exposure suffered from people living in
Tehran. Another limitation is due to the RR estimates
derived in studies of different populations in comparison
to the one under investigation. In particular, while for
PM10, SO2, NO2 and O3 the RRs were mainly based on
studies on the European population. The transferability
of the mortality effect estimates from the evidentiary
(e.g., the US cohort) to the target population, however, is
feasible if no compelling evidence that the target popula-
tion and the evidentiary population differ in the response
to the air pollution [33].
Conclusion
In conclusion, this study applied the AirQ software and
the approach proposed by the WHO to provide quanti-
tative data on the impact of PM10, SO2, NO2 and O3 on
the health of people living in a certain area. The results
are in line with those of other investigations and, despite
the limitations, which are in common to similar studies,
indicate that this method offers an effective and easy
tool, helpful in decision-making.
The magnitude of the health impact estimated for the
city of Tehran underscores the need for urgent action to
reduce the health burden of air pollution. Local author-
ities, through policies that aim mainly to reduce emis-
sions from urban transport and energy production, can
achieve sizeable health gains.Competing interests
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